Why it was recalled
Marketed Without An Approved NDA/ANDA: Contains an unapproved drug, ligandrol LGD-4033
Product description
LGD-Xtreme (ligandrol LGD-4033),capsules, 3 mg, 90-count bottle, Manufactured for Continuum Labs, Fort Lauderdale, FL
Lot numbers, UPCs & expiration codes
Lot # 21511166, Exp 11/18
Where it was sold
Nationwide and Brazil.
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0910-2016
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Mar 31, 2016
- FDA report date
- Jun 8, 2016
- Quantity
- 3,319 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Invisiblu International LLC
Original FDA data
Every field from FDA enforcement report D-0910-2016, exactly as published.
Show all FDA fields
- City
- Fort Lauderdale
- State
- FL
- Status
- Ongoing
- Country
- United States
- Event ID
- 73698
- Address
- 620 SE 13th St
- Code information
- Lot # 21511166, Exp 11/18
- Postal code
- 33316-2023
- Report date
- Jun 8, 2016
- Product type
- Drugs
- Recall number
- D-0910-2016
- Classification
- Class II
- Recalling firm
- Invisiblu International LLC
- Product quantity
- 3,319 bottles
- Reason for recall
- Marketed Without An Approved NDA/ANDA: Contains an unapproved drug, ligandrol LGD-4033
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- LGD-Xtreme (ligandrol LGD-4033),capsules, 3 mg, 90-count bottle, Manufactured for Continuum Labs, Fort Lauderdale, FL
- Distribution pattern
- Nationwide and Brazil.
- Recall initiation date
- Mar 31, 2016
- Initial firm notification
- Press Release
- Center classification date
- May 27, 2016